07 Jan 2001

Vigantoletten® 500 (Vigantoletten® 500/-1000 Tabletten) - Deutschland

Updated: 07 Jan 2001

Vigantoletten® 500 | -1000

Vorbeugung gegen Rachitis beim Sgl. Vorbeugung bei erkennbarem Risiko einer Vit.-D-Mangelerkrankung, Vorbeugung von Vit.-D-Mangelerscheinungen bei Verdauungsschwäche, z. B. durch chronische Darmerkrankungen, narbigen Umbau des Lebergewebes, Entfernung großer Teile des Magens oder Darms, Behandl. von Rachitis und Knochenerweichung durch Vit.-D-Mangel, unterstützende Behandl. bei Osteoporose.

Vigantoletten® 500 Description, Presentation and Dosage

Vigantoletten® 500 Description

Vigantoletten® 500 Drug Class Description

Andere Einzelstoffe

Vigantoletten® 500 Drug Description

1 Tbl. enth.: Colecalciferol 0,0125 mg/0,025 mg (entspr. 500 I.E./1000 I.E. Vit. D3).

Vigantoletten® 500 Generic Name

Vigantoletten® 500/-1000 Tabletten

Vigantoletten® 500 Presentation

Vigantoletten® 500 Presentation

Vigantoletten® 500/-1000

Vigantoletten® 500 Manufacturer

Merck

Related Learning Zones

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

Vigantoletten® 500 Dosage

Vigantoletten® 500 Adult Dosage

Siliciumdioxid, Maisstärke, Carboxymethylstärke-Natrium, Talkum, Glyceroltristearat, Cellulose, D-Mannitol, Gelatine, Saccharose, teilhydrierte Pflanzenöle (Sojaöl), 'alpha'-Tocopherol.

Vigantoletten® 500 Precautions, Reactions and Contraindications

Vigantoletten® 500 Special Precautions

Vigantoletten® 500 Special Precautions

V 15

Vigantoletten® 500 Adverse Reactions

Vigantoletten® 500 Adverse Reactions

V 15

Related Drugs - Rheumatology

Back to top